Distributed Bio Inc. Announces Collaboration with H3 Biomedicine

09:00 EDT 30 Oct 2018 | Businesswire

This article has expired, however you can still download the PDF.
Distributed Bio, the global leader in computational optimization of fully human monoclonal antibody libraries, today announced a discovery collaboration with H3 Biomedicine, Inc. designed to help accelerate the discovery of...

Other Sources for this Article

Distributed Bio Inc.
Giles Day, CEO, +1-415-489-0246


More From BioPortfolio on "Distributed Bio Inc. Announces Collaboration with H3 Biomedicine"

Quick Search


Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...